Affymax and investigators will make multiple presentations highlighting Hematide preclinical and clinical data in various treatment settings. These include preliminary results of a Phase 2 trial in hemodialysis patients who aren’t on an erythropoiesis stimulating agent , and interim results from an ongoing Phase 2 study in individuals with antibody-mediated pure crimson cell aplasia . Related StoriesDiets abundant with potassium can help prevent heart and kidney problems in individuals with type 2 diabetesESRD patients with multiple myeloma living longer than before, displays studyAdvances in nanofilter technology can lead to implantable surgically, artificial kidneyDetails of Hematide presentations at ASN are the following: *Note: All instances are detailed in Pacific Time Company Webcast Affymax will sponsor an trader webcast with Dr.This feedback has significantly exceeded our expectations. ‘.
AANMA companions with AAE and AAPA-AAI to build network concentrating on allergy, asthma care Allergy & Asthma Network Moms of Asthmatics , a leading patient education organization, is partnering with the Association of Asthma Educators and the American Academy of Doctor Assistants in Allergy, Asthma & Immunology within its try to build the only multidisciplinary, patient-centered network of healthcare professionals focused on allergy and asthma treatment. Asthma educators and doctor assistants offer a wealth of knowledge and expertise to greatly help educate and advocate for sufferers with asthma and allergies, says Tonya Winders, AANMA Chief Operating Officer.